| C006718 | 1,12-benzoperylene | "1,12-benzoperylene results in increased expression of SPON1 mRNA" | 26377693 |
| C026486 | 1,2,5,6-dibenzanthracene | "1,2,5,6-dibenzanthracene results in increased expression of SPON1 mRNA" | 26377693 |
| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPON1 mRNA" | 25510870 |
| C111118 | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl | "2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of SPON1 mRNA" | 19114083 |
| C013186 | 2,3-pentanedione | "2,3-pentanedione results in increased expression of SPON1 mRNA" | 25710175 |
| C081766 | 2,4,4'-trichlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPON1 mRNA" | 25510870 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPON1 mRNA" | 25510870 |
| C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPON1 mRNA" | 25510870 |
| C009407 | 2,5,2',5'-tetrachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPON1 mRNA" | 25510870 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of SPON1 mRNA" | 23196670 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPON1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPON1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPON1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPON1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPON1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPON1 mRNA" | 27188386 |
| C023829 | 4-nitroso-N-phenylaniline | SPON1 gene SNP affects the susceptibility to 4-nitroso-N-phenylaniline | 25622337 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPON1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPON1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPON1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPON1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPON1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPON1 mRNA" | 27188386 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of SPON1 mRNA | 17562736 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased methylation of SPON1 gene | 28458013 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of SPON1 mRNA | 23630614 |
| D006710 | Homocysteine | Homocysteine results in decreased expression of SPON1 mRNA | 17326132 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of SPON1 mRNA | 16483693 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of SPON1 mRNA | 26705709 |
| D001280 | Atrazine | Atrazine results in decreased expression of SPON1 mRNA | 25929836 |
| D001379 | Azathioprine | Azathioprine results in increased expression of SPON1 mRNA | 19192274 |
| C006703 | benzo(b)fluoranthene | benzo(b)fluoranthene results in increased expression of SPON1 mRNA | 26377693 |
| D019324 | beta-Naphthoflavone | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SPON1 mRNA | 18164116 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of SPON1 mRNA | 19770486|2261060 |
| D004958 | Estradiol | [Progesterone co-treated with Estradiol] results in decreased expression of SPON1 mRNA | 17404688 |
| D004958 | Estradiol | Estradiol results in increased expression of SPON1 mRNA | 19484750 |
| C006780 | bisphenol A | bisphenol A results in decreased methylation of SPON1 promoter | 27312807 |
| C006780 | bisphenol A | bisphenol A results in increased expression of SPON1 mRNA | 26063408 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of SPON1 mRNA | 25181051 |
| C006780 | bisphenol A | bisphenol A results in increased methylation of SPON1 gene | 28505145 |
| D015124 | 8-Bromo Cyclic Adenosine Monophosphate | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SPON1 mRNA | 20147733 |
| D002101 | Cacodylic Acid | Cacodylic Acid results in decreased expression of SPON1 mRNA | 16122865 |
| D007631 | Chlordecone | SPON1 gene SNP affects the susceptibility to Chlordecone | 25622337 |
| D002713 | Chlorine | [Ozone co-treated with Chlorine] affects the expression of SPON1 mRNA | 18636392 |
| D020245 | p-Chloromercuribenzoic Acid | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPON1 mRNA" | 27188386 |
| D020245 | p-Chloromercuribenzoic Acid | p-Chloromercuribenzoic Acid results in decreased expression of SPON1 mRNA | 26272509 |
| C023676 | chloroquine diphosphate | chloroquine diphosphate results in increased expression of SPON1 mRNA | 19192274 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of SPON1 | 20938992 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SPON1 gene | 20938992 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPON1 mRNA | 20938992 |
| D003078 | Colchicine | Colchicine results in increased expression of SPON1 mRNA | 20624997 |
| C408982 | CPG-oligonucleotide | CPG-oligonucleotide results in increased expression of SPON1 protein | 17727805 |
| D003561 | Cytarabine | Cytarabine results in decreased expression of SPON1 mRNA | 21198554 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of SPON1 mRNA | 28628672 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of SPON1 mRNA | 20032058 |
| D003907 | Dexamethasone | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of SPON1 mRNA] | 20032058 |
| D002945 | Cisplatin | SPON1 protein affects the susceptibility to Cisplatin | 16217747 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of SPON1 mRNA | 18042831 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SPON1 mRNA | 18164116 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of SPON1 mRNA | 17005392 |
| D004237 | Diuron | Diuron results in decreased expression of SPON1 mRNA | 25152437 |
| D004317 | Doxorubicin | Doxorubicin affects the expression of SPON1 mRNA | 15205334 |
| C118739 | entinostat | entinostat results in decreased expression of SPON1 mRNA | 26272509 |
| C118739 | entinostat | entinostat results in increased expression of SPON1 mRNA | 27188386 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPON1 mRNA" | 27188386 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of SPON1 mRNA | 17942748 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of SPON1 mRNA | 12655037|1583489 |
| D005419 | Flavonoids | Flavonoids results in increased expression of SPON1 mRNA | 18035473 |
| D005472 | Fluorouracil | Fluorouracil affects the expression of SPON1 mRNA | 15205334 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of SPON1 | 20938992 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SPON1 gene | 20938992 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPON1 mRNA | 20938992 |
| C039281 | furan | furan results in increased expression of SPON1 mRNA | 27387713 |
| D006052 | Gold Sodium Thiomalate | Gold Sodium Thiomalate results in increased expression of SPON1 mRNA | 19192274 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of SPON1 mRNA | 28628672 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of SPON1 mRNA | 28628672 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of SPON1 mRNA | 22235868 |
| C042720 | mercuric bromide | mercuric bromide results in decreased expression of SPON1 mRNA | 26272509 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPON1 mRNA" | 27188386 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of SPON1 | 20938992 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SPON1 gene | 20938992 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPON1 mRNA | 20938992 |
| D008727 | Methotrexate | Methotrexate results in increased expression of SPON1 mRNA | 19192274 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of SPON1 mRNA | 28001369 |
| D015735 | Mifepristone | Mifepristone results in decreased expression of SPON1 mRNA | 25972201 |
| D008942 | Mitoxantrone | SPON1 protein affects the susceptibility to Mitoxantrone | 16217747 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of SPON1 mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of SPON1 mRNA" | 25554681 |
| C572573 | N-nitroso-tris-chloroethylurea | [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SPON1 mRNA | 27935865 |
| C572573 | N-nitroso-tris-chloroethylurea | [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SPON1 mRNA | 27935865 |
| C025589 | ochratoxin A | ochratoxin A results in decreased methylation of SPON1 gene | 26431795 |
| C030110 | oxaliplatin | [oxaliplatin co-treated with Topotecan] results in increased expression of SPON1 mRNA | 25729387 |
| D010126 | Ozone | [Ozone co-treated with Chlorine] affects the expression of SPON1 mRNA | 18636392 |
| D000073878 | Palm Oil | Palm Oil results in increased expression of SPON1 mRNA | 18042831 |
| D052638 | Particulate Matter | [SPON1 gene mutant form affects the susceptibility to Particulate Matter] which results in decreased expression of SPON1 mRNA | 21222557|2122255 |
| C410127 | PCB 180 | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPON1 mRNA" | 25510870 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of SPON1 mRNA | 12082028 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPON1 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in decreased expression of SPON1 mRNA | 26272509 |
| C060836 | pioglitazone | [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SPON1 mRNA | 27935865 |
| C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SPON1 mRNA | 19710929 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of SPON1 mRNA | 12832660 |
| D011192 | Potassium Dichromate | Potassium Dichromate results in increased expression of SPON1 mRNA | 23608068 |
| D011374 | Progesterone | [Progesterone co-treated with Estradiol] results in decreased expression of SPON1 mRNA | 17404688 |
| D011441 | Propylthiouracil | Propylthiouracil results in decreased expression of SPON1 mRNA | 24780913 |
| C017947 | sodium arsenite | sodium arsenite affects the methylation of SPON1 gene | 28589171 |
| D053260 | Soot | Soot affects the expression of SPON1 mRNA | 26551751 |
| D053260 | Soot | Soot results in increased expression of SPON1 mRNA | 22461453 |
| D013629 | Tamoxifen | Tamoxifen results in increased expression of SPON1 mRNA | 25123088 |
| D013739 | Testosterone | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of SPON1 mRNA] | 20032058 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of SPON1 mRNA | 26377647 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of SPON1 mRNA | 27913140 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of SPON1 mRNA | 19770486|2527062 |
| C009495 | titanium dioxide | titanium dioxide results in increased expression of SPON1 mRNA | 23557971 |
| D019772 | Topotecan | [oxaliplatin co-treated with Topotecan] results in increased expression of SPON1 mRNA | 25729387 |
| D019772 | Topotecan | Topotecan results in increased expression of SPON1 mRNA | 25729387 |
| D014212 | Tretinoin | Tretinoin results in increased expression of SPON1 mRNA | 21934132 |
| C032910 | triadimefon | triadimefon results in increased expression of SPON1 mRNA | 26705709 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPON1 mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in decreased expression of SPON1 mRNA | 26272509 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPON1 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of SPON1 mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of SPON1 mRNA | 24383497|2627250 |
| D014635 | Valproic Acid | Valproic Acid results in increased methylation of SPON1 gene | 29154799 |
| D014640 | Vancomycin | Vancomycin results in decreased expression of SPON1 mRNA | 18930951 |
| D001335 | Vehicle Emissions | [SPON1 gene mutant form affects the susceptibility to Vehicle Emissions] which results in decreased expression of SPON1 mRNA | 21222557|2122255 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased methylation of SPON1 gene | 25560391 |
| D014747 | Vinblastine | Vinblastine results in increased expression of SPON1 mRNA | 20624997 |
| C025643 | vinclozolin | vinclozolin results in increased expression of SPON1 mRNA | 20566332 |
| D014750 | Vincristine | Vincristine results in increased expression of SPON1 mRNA | 20624997 |
| C581157 | XL147 | [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SPON1 mRNA | 27935865 |
| D015032 | Zinc | Zinc results in decreased expression of SPON1 mRNA | 18316168 |